MS NOW on MSN
David Ignatius: A week into this war, it is devastating a regime that has created so much turmoil
The Morning Joe panel discusses the first week of the war with Iran, including reports the UAE is moving to freeze Iranian assets.
A case of a 45-year-old construction worker with a history of intravenous drug use, homelessness, and occasional alcohol and tobacco use.
A bald eagle rescued from the icy Hudson River last month is showing signs of improvement at a Morris County wild bird ...
Fox Business on MSN
Oil prices surge: What it means for the US economy, jobs and the Fed
A panel discusses the impact of rising oil prices on the U.S. economy, noting decreased sensitivity to oil stocks and more on ‘Mornings with Maria.’ ...
Advanced Global Phase 3 Program for Treatment of Hepatitis C Virus (HCV) in 2025 with Topline Results from North American C-BEYOND Trial Expected ...
Cash and Investments -- $301.8 million as of December 31, 2025, sufficient to fully fund current Phase III HCV and new HEV programs through 2027. Phase III HCV Trials -- C BEYOND enrollment completed ...
Advanced Global Phase 3 Program for Treatment of Hepatitis C Virus (HCV) in 2025 with Topline Results from North American C-BEYOND Trial Expected Mid-2026 and Topline Results from C-FORWARD Trial Outs ...
Good afternoon, everyone, and welcome to the Atea Pharmaceuticals' Fourth Quarter 2025 Financial Results and Business Update Conference Call. [Operator Instructions] I would now like to turn the call ...
Compared to a multivitamin, whole foods like leafy greens, fruits, whole grains, and fish contain nutrients that are better absorbed and used by the body. Learn more.
The longtime pro-democracy activist and critic of Beijing was found guilty of sedition and colluding with foreign forces in a December verdict ...
Sacramento County health inspectors closed four eateries, including a cafe after they found approximately 100 fresh “shiny” mouse droppings in the facility. Meanwhile, 15 eateries received yellow ...
BBOT debuted as a publicly traded oncology company developing a differentiated portfolio of three clinical-stage small molecule inhibitors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results